Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Sino Biopharmaceutical Ltd (1177)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.84 -0.01    -0.35%
04:08:22 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG8167W1380 
  • Volume: 24,613,683
  • Bid/Ask: 2.83 / 2.84
  • Day's Range: 2.82 - 2.91
Sino Biopharmaceutical 2.84 -0.01 -0.35%

1177 Balance Sheet

 
Featured here, the Balance Sheet for Sino Biopharmaceutical Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 23805.53 23805.53 26977.27 26977.27
Cash and Short Term Investments 14118.18 14118.18 15676.4 15676.4
Cash - - - -
Cash & Equivalents 9451.88 9451.88 11577.19 11577.19
Short Term Investments 1553.26 1553.26 160.14 160.14
Total Receivables, Net 6198.61 6198.61 7188.86 7188.86
Accounts Receivables - Trade, Net 4596.2 4596.2 7108.97 7108.97
Total Inventory 1993.47 1993.47 2018.5 2018.5
Prepaid Expenses 582.57 582.57 2093.52 2093.52
Other Current Assets, Total 912.71 912.71 - -
Total Assets 63604.82 63604.82 65640.89 65640.89
Property/Plant/Equipment, Total - Net 9912.16 9912.16 9584.25 9584.25
Property/Plant/Equipment, Total - Gross 15392.77 15392.77 - -
Accumulated Depreciation, Total -5480.61 -5480.61 - -
Goodwill, Net 680.45 680.45 812.08 812.08
Intangibles, Net 2228.51 2228.51 2129.61 2129.61
Long Term Investments 25180.97 25180.97 24263.34 24263.34
Note Receivable - Long Term 1602.41 1602.41 79.89 79.89
Other Long Term Assets, Total 1230.18 1230.18 1365.43 1365.43
Other Assets, Total 1940.88 1940.88 -562.24 -562.24
Total Current Liabilities 22606.78 22606.78 26865.42 26865.42
Accounts Payable 1334.7 1334.7 2167.01 2167.01
Payable/Accrued - - - -
Accrued Expenses 6715.77 6715.77 - -
Notes Payable/Short Term Debt 136.13 136.13 - -
Current Port. of LT Debt/Capital Leases 11207.43 11207.43 10522.74 10522.74
Other Current liabilities, Total 3212.75 3212.75 14175.66 14175.66
Total Liabilities 25434.87 25434.87 29182.08 29182.08
Total Long Term Debt 1372.82 1372.82 1031.32 1031.32
Long Term Debt 1074.42 1074.42 702.08 702.08
Capital Lease Obligations 298.39 298.39 329.25 329.25
Deferred Income Tax 781.54 781.54 623.45 623.45
Minority Interest 7695.48 7695.48 6469.51 6469.51
Other Liabilities, Total -19487.9 -7157.88 -16978.2 -5807.62
Total Equity 38169.95 38169.95 36458.8 36458.8
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 414.62 414.62 414.62 414.62
Additional Paid-In Capital 12443 12443 12443 12443
Retained Earnings (Accumulated Deficit) 29335.08 29335.08 28640.96 28640.96
Treasury Stock - Common -1769.72 -1769.72 -1626.77 -1626.77
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -2253.02 -2253.02 -3413 -3413
Total Liabilities & Shareholders' Equity 63604.82 63604.82 65640.89 65640.89
Total Common Shares Outstanding 18347.12 18347.12 18407.24 18407.24
Total Preferred Shares Outstanding - - - -
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

1177 Comments

Write your thoughts about Sino Biopharmaceutical Ltd
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JAME Megueni
VRAQ Jun 29, 2022 10:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
HSBC Global Research: SINO BIOPHARM Acquisition of F-Star Should Improve Pipeline, Rating Buy
Reply
2 0
Report
JAME Megueni
VRAQ Feb 15, 2022 9:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
HSBC Global Research Cuts SINO BIOPHARM TP to $9, Rated Buy
Reply
0 0
Report
JAME Megueni
VRAQ Jan 20, 2022 8:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
UBS Adds SINO BIOPHARM TP to $11.6, Rated Buy
Reply
0 0
Report
JAME Megueni
VRAQ Sep 02, 2021 11:39PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
M Stanley Trims CHINA CINDA TP to $1.63; Rated Equalweight
Reply
0 0
Report
JAME Megueni
VRAQ Sep 02, 2021 11:39PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Daiwa Axes SINO BIOPHARM TP to $11; Rated Buy
Reply
0 0
Report
JAME Megueni
VRAQ Aug 18, 2021 11:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
SINO BIOPHARM Shr Once Rebounds Over 9% as Interim NP May Hike Over 5x
Reply
0 0
Report
JAME Megueni
VRAQ Jul 27, 2021 10:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
SINO BIOPHARM Repurchases $28.53M Shrs; Tse Ping, Tse Hsin Splurge Over $100M to Add Stakes
Reply
0 1
Report
Jarvis Wang
Jarvis Wang Jun 01, 2021 9:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
WHO agree SinoVac into EUA list at Jun 01, that Sino Biopharm have 15.3%
Reply
0 0
Report
JAME Megueni
VRAQ May 24, 2021 10:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Macquarie Upgrades SINO BIOPHARM to *Outperform* with $10.46 TP
Reply
1 0
Report
JAME Megueni
VRAQ Mar 15, 2021 10:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
JPM Raises SINO BIOPHARM TP to $13.5; Rated ***Overweight***
Reply
1 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email